Literature DB >> 11404496

Linear accelerator based radiosurgery as a salvage treatment for skull base and intracranial invasion of recurrent nasopharyngeal carcinomas.

H J Chen1, S W Leung, C Y Su.   

Abstract

Nasopharyngeal carcinoma is a common disease entity in Taiwan. It can spread in the prestyloid, retrostyloid compartments, parapharyngeal space, and skull base, and induce paralysis of cranial nerves. We have treated more than 1,500 cases in the past 14 years. Since 1994, we have treated 11 cases of nasopharyngeal carcinomas with skull base invasion by linear accelerator-based stereotactic radiosurgery. There were six male and five female patients. The mean age was 48.4 years. Seven patients had symptoms of low cranial nerves. For these patients, conformal radiotherapy plus brachytherapy was used for the masses beyond the skull base. Stereotactic radiosurgery with a dose of 10 Gy to 19 Gy for one treatment was used for the masses invading the skull base. Eight patients died in follow-up periods from 5 months to 2 years 7 months. Approximately half of patients revealed good response of tumor to radiosurgery. Two patients demonstrated no response of tumors to radiosurgery. Stereotactic radiosurgery may be an adjuvant treatment for recurrent nasopharyngeal carcinomas with skull base and intracranial invasion.

Entities:  

Mesh:

Year:  2001        PMID: 11404496     DOI: 10.1097/00000421-200106000-00009

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

1.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

Review 2.  The evolving role of stereotactic radiosurgery for patients with skull base tumors.

Authors:  Bruce E Pollock; Robert L Foote
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

3.  Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases.

Authors:  Xin Wang; Yuan-Yuan Wang; Peng Jiang; Jian-Jun Ma; Zhen Qu; Han-Chen Liu; Shan-Shan Wang; Yi-Shan Wang
Journal:  Exp Ther Med       Date:  2011-09-23       Impact factor: 2.447

4.  Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.

Authors:  Daniel T T Chua; Shao-Xiong Wu; Victor Lee; Janice Tsang
Journal:  Head Neck Oncol       Date:  2009-05-23

5.  Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery.

Authors:  Daniel T T Chua; Kwan-Ngai Hung; Victor Lee; Sherry C Y Ng; Janice Tsang
Journal:  BMC Cancer       Date:  2009-04-29       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.